Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

He Wei,Oliver T. Bruns,Michael G. Kaul,Eric C. Hansen,Mariya Barch,Agata Wiśniowska,Ou Chen,Yue Chen,Nan Li,Satoshi Okada,Jose M. Cordero,Markus Heine,Christian T. Farrar,Daniel M. Montana,Gerhard Adam,Harald Ittrich,Alan Jasanoff,Peter Nielsen,Moungi G. Bawendi

DOI: https://doi.org/10.1073/pnas.1620145114

IF: 11.1

2017-02-13

Proceedings of the National Academy of Sciences

Abstract:Significance Gadolinium (Gd)-based contrast agents (GBCAs) are currently the mainstream clinical MRI contrast agents. Some GBCAs have shown a long-term toxicity—nephrogenic systemic fibrosis (NSF)—and Gd depositions in the brain. The NSF has triggered a Food and Drug Administration (FDA) black-box warning and a contraindication of some GBCAs. The finding of Gd depositions led to an ongoing FDA investigation to monitor their possible long-term adverse effects. Here, we present T 1 -weighted contrast-enhanced MR imaging and angiography using zwitterion-coated exceedingly small superparamagnetic iron oxide nanoparticles (ZES-SPIONs) in mice and rats. Renal clearance and biodistribution results further demonstrate that ZES-SPIONs are qualitatively different from previously reported SPIONs. This work may open up opportunities to develop exceedingly small SPIONs that show effective T 1 contrast as Gd-free alternatives to GBCAs.